Signet ring cells are a distinct histopathological finding important for oncology pharmacists to recognize, as they are linked to aggressive tumor biology.
Definition
- Epithelial malignant cells with intracytoplasmic mucin vacuoles that push the nucleus to the periphery.
- This creates the appearance of a signet ring under the microscope.
Oncology Relevance
- Most commonly seen in:
- Gastric adenocarcinoma (diffuse type, “linitis plastica”)
- Breast carcinoma (lobular type)
- Also seen in colon, bladder, and ovarian cancers.
- Clinical significance:
- Often associated with poor prognosis.
- Frequently indicates diffuse infiltration rather than forming distinct masses (especially in stomach and breast).
- May lead to early metastasis.
Pharmacist Considerations
- Gastric cancer with signet ring cells:
- Less responsive to standard chemotherapy (like ECF/EOX).
- Aggressive disease course → consider multidisciplinary management.
- Breast lobular carcinoma:
- Hormone receptor–positive more often, but unique metastatic patterns (GI, peritoneum).
- Treatment decisions may be guided by histology + molecular markers (HER2, PD-L1, MSI status, etc.).
In summary: Signet ring cells are malignant epithelial cells with mucin displacing the nucleus, most commonly linked to gastric and lobular breast cancers, usually conferring a worse prognosis.